A report has highlighted that Cognitive Behavioural Therapy (CBT) delivered by respiratory nurses is clinically effective and cost-effective for patients with chronic obstructive pulmonary disease and symptoms of anxiety.
The study, “Randomised controlled trial of cognitive behavioural therapy in COPD*”, downloadable as a PDF here, supports the benefits of CBT.
Anxiety and depression are likely in those with COPD and have a significant impact on breathlessness, quality of life, length of hospital stay, readmission rates and mortality.
Guidelines for the treatment of anxiety and depression recommend psychological treatment including CBT which is a “talking” treatment, which explores the link between a patient’s situation, physical symptoms, thoughts, emotions and behaviour.
St Christopher’s has been aware for some time of the benefits of CBT and has written accredited courses to develop the knowledge and skills of registered staff working with patients at end of life and with long term conditions.
St Christopher’s offers a series of events developed by our CBT specialists providing one day introductory and subject specific courses, a three day foundation course and a six day applied ‘CBT first-aider’ course providing CBT skills for health professionals. These CBT courses will develop your knowledge and skills to improve the wellbeing of those for whom you care.
Foundations in Cognitive Behavioural Therapy (CBT), a three day course, provides foundation level understanding of CBT and equips participants with the knowledge and understanding required to underpin new skills to incorporate into everyday practice.
Applied Cognitive Behavioural Therapy, a six day course, enables clinicians to develop a set of CBT-based skills and be able to apply these in their usual role, in order to help their patients in a coherent and skilled manner.
*Heslop-Marshall K, Baker C, Carrick-Sen D, et al. Randomised controlled trial of cognitive behavioural therapy in COPD. ERJ Open Res 2018; 4: 00094-2018 https://doi.org/10.1183/23120541.00094-2018].
7, December 2018